Sandbox Financial Partners, LLC Aeterna Zentaris Inc. Transaction History

Sandbox Financial Partners, LLC

  • $276 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021
SELL
$0.51 - $3.34 $9,945 - $65,130
-19,500 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$0.3 - $0.44 $5,850 - $8,580
19,500 New
19,500 $8,000

About Aeterna Zentaris Inc.

AEZS Quotes by TradingView
  • Ticker AEZS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,855,880
  • Market Cap $19.4M
  • Description
  • Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...
More about AEZS
Track This Portfolio

Track Sandbox Financial Partners, LLC Portfolio

Follow Sandbox Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandbox Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandbox Financial Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email